Haplotypes | DM (N =63) | PM (N = 18) | Myositis with ILD | Myositis with dysphagia | Control (N =100) | Controls vs. indicated patients ( p; OR [95% CI]) | |||
---|---|---|---|---|---|---|---|---|---|
DRB1-DQA1-DQB1 | n (%) | n (%) | n (%) N = 36 | n (%), N = 9 | n (%) | DM | PM | Myositis with ILD | Myositis with dysphagia |
03-05-02 | 2 (1.59) | 2 (5.56) | 2 (2.78) | 0 (0.00) | 11 (5.50) | n/s | n/s | n/s | n/s |
04-03-03 | 6 (4.36) | 1 (2.78) | 5 (6.94) | 1 (5.56) | 9 (4.50) | n/s | n/s | n/s | n/s |
04-03-04 | 5 (3.97) | 2 (5.56) | 5 (6.94) | 1 (5.56) | 6 (3.00) | n/s | n/s | n/s | n/s |
07-01-02 | 12 (9.52) | 1 (2.78) | 8 (11.11) | 2 (11.11) | 7 (3.50) | 0.031; 2.90 | n/s | 0.021; 3.45 | n/s |
(1.02–8.93) | (1.04–11.58) | ||||||||
07-03-02 | 6 (4.76) | 0 (0.00) | 3 (4.17) | 2 (11.11) | 11 (5.50) | n/s | n/s | n/s | n/s |
08-01-06 | 13 (10.32) | 3 (8.33) | 6 (8.33) | 2 (11.11) | 13 (6.50) | n/s | n/s | n/s | n/s |
09-03-03 | 17 (13.49) | 2 (5.56) | 3 (4.17) | 3 (16.67) | 20 (10.00) | n/s | n/s | n/s | n/s |
11-05-03 | 3 (2.38) | 1 (2.78) | 1 (1.39) | 0 (0.00) | 7 (3.50) | n/s | n/s | n/s | n/s |
12-01-03 | 11 (8.73) | 2 (5.56) | 8 (11.11) | 0 (0.00) | 11 (5.50) | n/s | n/s | n/s | n/s |
13-01-06 | 7 (5.56) | 0 (0.00) | 2 (2.78) | 1 (5.56) | 7 (3.50) | n/s | n/s | n/s | n/s |
14-01-05 | 2 (1.59) | 1 (2.78) | 0 (0.00) | 2 (11.11) | 7 (3.50) | n/s | n/s | n/s | n/s |
15-01-06 | 7 (5.56) | 3 (8.33) | 3 (4.17) | 1 (5.56) | 19 (9.50) | n/s | n/s | n/s | n/s |